Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: predictors of use and association with toxicities.

Abstract

BACKGROUND Intensity modulated radiotherapy for stage III lung cancer has become commonplace in the United States in the absence of randomized controlled trials. We used a large, population-based database to determine which factors led to increased utilization of IMRT and to evaluate associations of IMRT with toxicities. METHODS The Surveillance… (More)
DOI: 10.1016/j.lungcan.2013.08.015

Topics

4 Figures and Tables

Slides referencing similar topics